Adial Pharmaceuticals

ADILNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.532 M

$3.98 -17.08%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$7.98M

Loss-making

Shares outstanding

1,427,970

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#437Processa PharmaceuticalsPCSA$8.55M
#438SoligenixSNGX$8.53M
#439Adial PharmaceuticalsADIL$8.53M
#440ImmuronIMRN$8.32M
#441Kairos PharmaKAPA$8.26M

Where these numbers come from

Share counts and financials for Adial Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.